TrumpRx is intended to help Americans, especially the uninsured or those with high-deductible plans, find lower prices on brand-name prescription drugs. What's the difference between TrumpRx and ...

The Trump administration finally has unveiled TrumpRx.gov, a website for consumers to find discounts on brand-name drugs if they pay cash instead of using their health insurance. It launched Thursday ...

Feb 5 (Reuters) - (This Feb 5 story has been corrected to fix Prolia's 2025 sales to $4.4 billion, not $1.05 billion, in paragraph 5) Sign up here. Its pharmacy benefit management unit, Caremark, will ...

CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity and Tymlos. Like Humira and its biosimilars, Prolia is a specialty drug ...

The owners of an independent pharmacy have called the roll out of the Bermuda Health Council’s new formulary a disaster and have questioned the fairness of the process. After struggling to get their ...

Ostarine held the promise of profound medical treatments. Something unexpected happened on the way to F.D.A. approval. By Jason Stallman Twenty-five years later, James Dalton proudly recalled “that ...

With appreciation for feedback from Mark Fendrick, Director of the Value-Based Insurance Design (V-BID) Center at the University of Michigan; Daneen Sekoni, Vice President of Policy and Advocacy at ...

The Centers for Medicare & Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of the Medicare Drug Price Negotiation Program. These are high-cost drugs covered ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug Price Negotiation Program, including the high-cost medications Botox and ...

Zepbound, which contains the active ingredient tirzepatide, has Food and Drug Administration (FDA) approval for the following: weight management in adults with obesity weight management in adults with ...

ST. LOUIS (CN) — Novartis Pharmacy hopes a recent ruling by the Eighth Circuit will bolster its efforts in the same court to block a Missouri law requiring the drug giant to give medical providers ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...